Symbicort
Designed to manage asthma and chronic obstructive pulmonary disease, intended to alleviate airway inflammation and support breathing function in patients.
Strengths: 160/4.5mcg
Where to Check Availability
Medicine details
- Alternative names
Budesonide Formoterol Inhaler; Budesonide Formoterol Rotacaps Inhaler
- Therapeutic class
Inhaled Corticosteroid / Long-acting Beta2 Agonist
- Pharmacological class
Corticosteroid; Beta2-adrenergic Agonist
- Contraindications
hypersensitivity to active substances
- Minor side effects
headache; palpitations
- Moderate side effects
oral candidiasis; throat irritation
- Dosage forms
Inhalation powder
- Administration route
Inhalation use
- Prescription status
POM
- Manufacturer
AstraZeneca
- Onset Time
1–3 minutes
- Duration
12 hours
- Storage instructions
Store at room temperature below 30°C.
- Drug interactions
beta blockers; ketoconazole
- Age restrictions
Children and adults, as prescribed.
Precautions and warnings
rinse mouth after use to prevent fungal infection; monitor for increased heart rate
Serious side effects
bronchospasm — requires immediate medical attention; pneumonia — requires immediate medical attention
Patient summary
Designed to manage asthma and chronic obstructive pulmonary disease, intended to alleviate airway inflammation and support breathing function in patients.
Mechanism of action
This medication combines an inhaled corticosteroid, which reduces inflammation and swelling in the airways, and a long-acting beta2 agonist, which relaxes the bronchial muscles. Together, they provide both preventive control and rapid relief by maintaining open airways and reducing allergic responses.
Pregnancy and breastfeeding
Pregnancy: use only if clearly indicated after medical assessment. Breastfeeding: use with caution as these components pass into breast milk.
Symbicort
Designed to manage asthma and chronic obstructive pulmonary disease, intended to alleviate airway inflammation and support breathing function in patients.
Editorial Notes
- Active ingredient(s): Budesonide, Formoterol
- Listed indication(s): Asthma, Chronic Obstructive Pulmonary Disease
Available option
- 3 inhalers - 160/4.5 mcg982-160-4-5-mcg-12197